Search
for
Sort by
Research 30 of 1000+
- 316 Role of platelet and growth factor concentration in platelet rich plasma therapeutic response to alopecia
- Activation of platelet-rich plasma by pulse electric fields: Voltage, pulse width and calcium concentration can be used to control and tune the release of growth factors, serotonin and hemoglobin
- Growth factor concentrations in platelet‐rich plasma for androgenetic alopecia: An intra‐subject, randomized, blinded, placebo‐controlled, pilot study
- Platelet-Rich Plasma Contains High Concentrations of DKK1, A Potent Inhibitor of Wnt Signaling that Limits Bone Regeneration and Hair Growth
- Regularities of Change Concentrations of Interleukin-17A, Interleukin-2 and Interleukin-10 in the Blood of People with Alopecia Areata before and after Treatment with Platelet-Rich Plasma
- Systematic Review—The Potential Implications of Different Platelet-Rich Plasma (PRP) Concentrations in Regenerative Medicine for Tissue Repair
- Technical Procedures for Preparation and Administration of Platelet-Rich Plasma and Related Products: A Scoping Review
- Comparative (quantitative and qualitative) analysis of three different reagents for preparation of platelet-rich plasma for hair rejuvenation
- Optimisation of Centrifugal Speed for PRPBAG<sup>®</sup>: A Novel Multiple Bag System for Preparing Platelet-Rich Plasma
- Optimized Platelet-Rich Plasma Preparations for a Consistently High Platelet Capture Rate, Bioformulation Flexibility, and Red Blood Cell Reduction Using a Single-Spin Device
- Platelet-rich plasma in androgenetic alopecia
- Commentary on: Platelet-Rich Plasma and Stem Cells for Hair Growth: A Review of the Literature
- Centrifugation Determines What Is in the Syringe, Not What Happens to the Patient: A Systematic Meta-Analysis of Platelet-Rich Plasma Preparation, Platelet Integrity, Cell Counts, Growth Factors and Clinical Outcomes in Regenerative Medicine
- Application of Platelet-Rich Gel in Repairing Scalp Defects Combined with Skull Exposure: A Case Series Analysis
- 484 FDA cleared devices produce inconsistent platelet-rich plasma product
- Comparative Evaluation of Buffy Coat–Derived and Apheresis Platelet-Rich Plasma in the Treatment of Androgenetic Alopecia: Laboratory and Clinical Insights
- Effectiveness of Autologous Platelet-Rich Plasma for Androgenetic Alopecia: A Double-Center, Non-Controlled, Randomized Clinical Study in Vietnam
- Commentary on: The Effects of Lower vs Higher Cell Number of Platelet-Rich Plasma (PRP) in Hair Density and Diameter in Androgenetic Alopecia (AGA): A Randomized, Double-Blinded, Placebo, Parallel-Group Half-Scalp IRB Study
- Platelet-Rich Plasma in the Treatment of Androgenetic Alopecia: An Equation with Many Unknowns
- Role of Platelet-rich Plasma in the Management of Androgenetic Alopecia
- A Monte Carlo Simulation Framework to Quantify Platelet Dose Variability in Platelet-Rich Plasma Therapies
- Scalp hair cortisol concentration in patients with alopecia areata and correlate its level with the disease variables
- Evaluation of Not-Activated and Activated PRP in Hair Loss Treatment: Role of Growth Factor and Cytokine Concentrations Obtained by Different Collection Systems
- Androgenetic Alopecia: A Chronic or Pubertal Onset Disease Retarded by Blood Donation
- Supplementary file 1_Comparison of single-spin to double-spin platelet-rich plasma centrifugation methods in the treatment of androgenic alopecia: a systematic review and meta-analysis of randomized controlled trials.pdf
- A Simple Drug Delivery System for Platelet-Derived Bioactive Molecules, to Improve Melanocyte Stimulation in Vitiligo Treatment
- Platelet-rich plasma by single-spin process in male pattern androgenetic alopecia: Is it an effective treatment?
- Response to: “Minimum requirements for reporting clinical trials evaluating the therapeutic potential of platelet-rich plasma”
- Supplementary file 2_Comparison of single-spin to double-spin platelet-rich plasma centrifugation methods in the treatment of androgenic alopecia: a systematic review and meta-analysis of randomized controlled trials.docx
- The Tumor Necrosis Factor-α Level in Platelet-Rich Plasma Might Be Associated with Treatment Outcome in Patients with Interstitial Cystitis/Bladder Pain Syndrome or Recurrent Urinary Tract Infection